Shanghai Fosun Pharmaceutical (Group) Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Fosun Pharmaceutical (Group) has a total shareholder equity of CN¥57.5B and total debt of CN¥32.9B, which brings its debt-to-equity ratio to 57.2%. Its total assets and total liabilities are CN¥113.7B and CN¥56.2B respectively. Shanghai Fosun Pharmaceutical (Group)'s EBIT is CN¥1.1B making its interest coverage ratio -0.5. It has cash and short-term investments of CN¥15.0B.
Key information
57.2%
Debt to equity ratio
CN¥32.90b
Debt
Interest coverage ratio | -0.5x |
Cash | CN¥15.02b |
Equity | CN¥57.54b |
Total liabilities | CN¥56.21b |
Total assets | CN¥113.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 08HH's short term assets (CN¥33.8B) exceed its short term liabilities (CN¥33.6B).
Long Term Liabilities: 08HH's short term assets (CN¥33.8B) exceed its long term liabilities (CN¥22.6B).
Debt to Equity History and Analysis
Debt Level: 08HH's net debt to equity ratio (31.1%) is considered satisfactory.
Reducing Debt: 08HH's debt to equity ratio has reduced from 68.1% to 57.2% over the past 5 years.
Debt Coverage: 08HH's debt is not well covered by operating cash flow (10.5%).
Interest Coverage: 08HH earns more interest than it pays, so coverage of interest payments is not a concern.